The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Galectin‐1 expression in cancer‐associated stromal cells correlates tumor invasiveness and tumor progression in breast cancer
Open accessAbstract
Understanding the molecular background of breast cancer biology is critical in developing new biomarkers for earlier diagnosis and more optimized treatment. We performed a proteomic analysis of human breast carcinoma tissues to investigate the tumor‐specific protein expression in breast carcinoma. Using 2‐dimensional electorphoresis (2‐DE) and matrix‐assisted laser desorption/ionization‐time of flight‐mass spectrometry (MALDI‐TOF‐MS), we were able to identify a list of proteins which are upregulated in cancerous tissue. There was significant increase of galectin‐1 expression in all cancerous tissues compared to noncancerous tissues, and its increased expression was further confirmed by western blot immunostaining. Subsequent immunohistochemical staining against galectin‐1 in 105 breast cancer specimens showed significant correlation between galectin‐1 expression in cancer‐associated stromal cells and tumor invasiveness, T stage, TNM stage, and axillary lymph node metastasis. Galectin‐1 expressionin cancer cells showed no correlation to above‐mentioned pathologic variables. Hormonal receptor status and galectin‐1 expression showed no correlation. This study demonstrates the upregulation of galectin‐1 in breast carcinoma tissues and the clinical significance of galectin‐1 in breast cancer patients. Our data supports the recently highlighted roles of galectin‐1 in cancer‐associated stroma and in tumor immune privilege. © 2006 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
White, D. E., Kurpios, N. A., Zuo, D., Hassell, J. A., Blaess, S., Mueller, U., & Muller, W. J. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.025 · Cited by 413 · cited 1×
“Indeed, this subunit of integrin is shown to be critical for the carcinogenesis and cancer progression in a mouse model of human breast cancer.(33) Cancer-associated stroma is also the place where tumor-immune interactions are operated by diverse inflammatory cells and proinflammatory cytokines.”
Background
Cited by
Role of tumor microenvironment in tumorigenesis
Wang, M., Zhao, J., Zhang, L., Wei, F., Lian, Y., Wu, Y., Gong, Z., Zhang, S., Zhou, J., Cao, K., et al. (2017) · Journal of Cancer · doi:10.7150/jca.17648 · Cited by 1,404
Galectins: structure, function and therapeutic potential
Yang, R.-Y., Rabinovich, G. A., & Liu, F.-T. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000719 · Cited by 862
Pectin – An emerging new bioactive food polysaccharide
Maxwell, E. G., Belshaw, N. J., Waldron, K. W., & Morris, V. J. (2012) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2011.11.002 · Cited by 432
Bu, L., Baba, H., Yoshida, N., Miyake, K., Yasuda, T., Uchihara, T., Tan, P., & Ishimoto, T. (2019) · Oncogene · doi:10.1038/s41388-019-0765-y · Cited by 329
Galectin expression in cancer diagnosis and prognosis: A systematic review
Thijssen, V. L., Heusschen, R., Caers, J., & Griffioen, A. W. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.03.003 · Cited by 279
Dalotto-Moreno, T., Croci, D. O., Cerliani, J. P., Martinez-Allo, V. C., Dergan-Dylon, S., Méndez-Huergo, S. P., Stupirski, J. C., Mazal, D., Osinaga, E., Toscano, M. A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2418 · Cited by 261
Metadata
- Authors
- Jung, E., Moon, H., Cho, B. I., Jeong, C., Joo, Y., Lee, Y., Hong, S., Choi, S., Ha, W., Kim, J. W., Lee, C., Lee, J. S., & Park, S.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2007-03-27
- Volume
- 120
- Issue
- 11
- Pages
- 2331-2338
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2010026333
- Cited by
- 166
- References
- 1
- FWCI
- 4.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.